v-Crk Modulation of Growth Factor-induced PC12 Cell Differentiation Involves the Src Homology 2 Domain of v-Crk and Sustained Activation of the Ras/Mitogen-activated Protein Kinase Pathway (*)

Nerve growth factor (NGF) and epidermal growth factor (EGF) elicit contrasting actions on PC12 pheochromocytoma cells; NGF causes neuronal differentiation, and EGF induces proliferation. However, ectopic expression of the Src homology 2 (SH2) and SH3-containing oncogenic adaptor protein v-Crk in PC12 cells results in EGF-inducible neuronal differentiation (Hempstead, B. L., Birge, R. B., Fajardo, J. E., Glassman, R., Mahadeo, D., Kraemer, R., and Hanafusa, H.(1994) Mol. Cell. Biol. 14, 1964-1971). Here we show that v-Crk complexes with both the tyrosine-phosphorylated EGF receptor and the Ras guanine nucleotide exchange factor SOS in PC12 cells and is involved in an pathway analogous to that of Grb2. Expression of v-Crk results in an enhanced and sustained activation of Ras and mitogen-activated protein (MAP) kinase following EGF or NGF stimulation, implying that v-Crk can couple divergent tyrosine kinase pathways to Ras. To investigate the causal relationship between EGF receptor binding, MAP kinase activation, and neurite outgrowth, we stably expressed two v-Crk SH2 point mutants, v-Crk(R273N) and v-Crk(H294R) in PC12 cells. Mutations within the SH2 domain of v-Crk block binding of v-Crk to the tyrosine phosphorylated EGF receptor, compromise v-Crk's ability to cause EGF-dependent neurite outgrowth, and act in a dominant negative manner for NGF-induced neurite outgrowth. However, the kinetics of MAP kinase activation in EGF- or NGF-treated v-Crk(R273N)PC12 cells was comparable with that in v-CrkPC12 cells. These data are consistent with a model in which v-Crk regulates the strength of a tyrosine kinase signal leading to prolonged activation of Ras and MAP kinase. However, the experiments with the SH2 mutants suggest that sustained activation, by itself, may not be sufficient to switch the fate of v-CrkPC12 cells from proliferation toward differentiation.

[1]  L. Greene,et al.  Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. , 1976, Proceedings of the National Academy of Sciences of the United States of America.

[2]  L. Greene,et al.  PC12 Pheochromocytoma Cultures in Neurobiological Research , 1982 .

[3]  J. Wang.  Isolation of antibodies for phosphotyrosine by immunization with a v-abl oncogene-encoded protein , 1985, Molecular and cellular biology.

[4]  A. Ogura,et al.  Sarcoma viruses carrying ras oncogenes induce differentiation-associated properties in a neuronal cell line , 1985, Nature.

[5]  S. Halegoua,et al.  Inhibition of growth factor-induced differentiation of PC12 cells by microinjection of antibody to ras p21 , 1986, Nature.

[6]  N. Rosenthal.  Identification of regulatory elements of cloned genes with functional assays. , 1987, Methods in enzymology.

[7]  D. Boettiger,et al.  Epitope mapping of monoclonal antibodies to gag protein p19 of avian sarcoma and leukaemia viruses. , 1987, The Journal of general virology.

[8]  B. Mayer,et al.  A novel viral oncogene with structural similarity to phospholipase C , 1988, Nature.

[9]  G. Cooper,et al.  Relationship among guanine nucleotide exchange, GTP hydrolysis, and transforming potential of mutated ras proteins , 1988, Molecular and cellular biology.

[10]  Joseph Schlessinger,et al.  Signal transduction by receptors with tyrosine kinase activity , 1990, Cell.

[11]  B. Mayer,et al.  Mutagenic analysis of the v-crk oncogene: requirement for SH2 and SH3 domains and correlation between increased cellular phosphotyrosine and transformation , 1990, Journal of virology.

[12]  B. Mayer,et al.  Binding of transforming protein, P47gag-crk, to a broad range of phosphotyrosine-containing proteins. , 1990, Science.

[13]  D. Lowy,et al.  The bovine papillomavirus E5 oncogene can cooperate with ras: identification of p21 amino acids critical for transformation by c-rasH but not v-rasH , 1991, Molecular and cellular biology.

[14]  S. Green,et al.  NGF and EGF rapidly activate p21 ras in PC12 cells by distinct, convergent pathways involving tyrosine phosphorylation , 1991, Neuron.

[15]  J. Brugge,et al.  Signal transduction by nerve growth factor and fibroblast growth factor in PC12 cells requires a sequence of src and ras actions , 1991, The Journal of cell biology.

[16]  L. Cantley,et al.  Oncogenes and signal transduction , 1991, Cell.

[17]  D. Kaplan,et al.  The trk proto-oncogene product: a signal transducing receptor for nerve growth factor. , 1991, Science.

[18]  S. Alemà,et al.  The mechanism of action of nerve growth factor. , 1991, Annual review of pharmacology and toxicology.

[19]  Sheila M. Thomas,et al.  Association of the Shc and Grb2/Sem5 SH2-containing proteins is implicated in activation of the Ras pathway by tyrosine kinases , 1992, Nature.

[20]  B. Margolis,et al.  Proteins with SH2 domains: transducers in the tyrosine kinase signaling pathway. , 1992, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[21]  L. Heasley,et al.  The beta-PDGF receptor induces neuronal differentiation of PC12 cells. , 1992, Molecular biology of the cell.

[22]  M. Pazin,et al.  Triggering signaling cascades by receptor tyrosine kinases. , 1992, Trends in biochemical sciences.

[23]  P. Cohen,et al.  Sustained activation of the mitogen-activated protein (MAP) kinase cascade may be required for differentiation of PC12 cells. Comparison of the effects of nerve growth factor and epidermal growth factor. , 1992, The Biochemical journal.

[24]  T. Pawson,et al.  Identification of residues in GTPase-activating protein Src homology 2 domains that control binding to tyrosine phosphorylated growth factor receptors and p62. , 1992, The Journal of biological chemistry.

[25]  J. Blenis,et al.  ras mediates nerve growth factor receptor modulation of three signal-transducing protein kinases: MAP kinase, Raf-1, and RSK , 1992, Cell.

[26]  T. Pawson,et al.  SH2 and SH3 domains: From structure to function , 1992, Cell.

[27]  M. Chao.  Growth factor signaling: Where is the specificity? , 1992, Cell.

[28]  L. Greene,et al.  NGF and other growth factors induce an association between ERK1 and the NGF receptor, gp140prototrk , 1992, Neuron.

[29]  M. Matsuda,et al.  Both the SH2 and SH3 domains of human CRK protein are required for neuronal differentiation of PC12 cells , 1993, Molecular and cellular biology.

[30]  J. Kuriyan,et al.  Binding of a high affinity phosphotyrosyl peptide to the Src SH2 domain: Crystal structures of the complexed and peptide-free forms , 1993, Cell.

[31]  T. Roberts,et al.  The cytoplasmic raf oncogene induces a neuronal phenotype in PC12 cells: a potential role for cellular raf kinases in neuronal growth factor signal transduction. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[32]  D. Baltimore,et al.  Signalling through SH2 and SH3 domains. , 1993, Trends in cell biology.

[33]  R. Weinberg,et al.  Association of Sos Ras exchange protein with Grb2 is implicated in tyrosine kinase signal transduction and transformation , 1993, Nature.

[34]  T. Pawson,et al.  The SH2 and SH3 domains of mammalian Grb2 couple the EGF receptor to the Ras activator mSos1 , 1993, Nature.

[35]  W. Fantl,et al.  Signalling by receptor tyrosine kinases. , 1993, Annual review of biochemistry.

[36]  R. Birge,et al.  Closing in on SH2 specificity. , 1993, Science.

[37]  T. Pawson,et al.  Molecular cloning of the mouse grb2 gene: differential interaction of the Grb2 adaptor protein with epidermal growth factor and nerve growth factor receptors , 1993, Molecular and cellular biology.

[38]  G. D’Arcangelo,et al.  A branched signaling pathway for nerve growth factor is revealed by Src-, Ras-, and Raf-mediated gene inductions , 1993, Molecular and cellular biology.

[39]  D. Bar-Sagi,et al.  Grb2 mediates the EGF-dependent activation of guanine nucleotide exchange on Ras , 1993, Nature.

[40]  S. Feller,et al.  c‐Abl kinase regulates the protein binding activity of c‐Crk. , 1994, The EMBO journal.

[41]  R. Birge,et al.  Expression of the v-crk oncogene product in PC12 cells results in rapid differentiation by both nerve growth factor- and epidermal growth factor-dependent pathways , 1994, Molecular and cellular biology.

[42]  J. Olefsky,et al.  The signaling pathway coupling epidermal growth factor receptors to activation of p21ras. , 1994, The Journal of biological chemistry.

[43]  C. Marshall,et al.  Activation of MAP kinase kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH 3T3 cells , 1994, Cell.

[44]  Ivan Dikic,et al.  PC12 cells overexpressing the insulin receptor undergo insulin-dependent neuronal differentiation , 1994, Current Biology.

[45]  Michael Karin,et al.  Membrane targeting of the nucleotide exchange factor Sos is sufficient for activating the Ras signaling pathway , 1994, Cell.

[46]  A. Cherniack,et al.  Phosphorylation of the Ras nucleotide exchange factor son of sevenless by mitogen-activated protein kinase. , 1994, The Journal of biological chemistry.

[47]  P. Cohen,et al.  EGF triggers neuronal differentiation of PC12 cells that overexpress the EGF receptor , 1994, Current Biology.

[48]  M. Shibuya,et al.  C3G, a guanine nucleotide-releasing protein expressed ubiquitously, binds to the Src homology 3 domains of CRK and GRB2/ASH proteins. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[49]  R. Campenot,et al.  NGF and the local control of nerve terminal growth. , 1994, Journal of neurobiology.

[50]  T. Takenawa,et al.  Different interactions of Grb2/Ash molecule with the NGF and EGF receptors in rat pheochromocytoma PC12 cells. , 1994, Oncogene.

[51]  A. Ullrich,et al.  Neuronal differentiation signals are controlled by nerve growth factor receptor/Trk binding sites for SHC and PLC gamma. , 1994, The EMBO journal.